Skip to content

MEPHAR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEPHAR

BE 0424.193.569
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€34,378
2024 · €10,306-€44,684
Equity
€426,042
2024 · €460,420-€34,378
Cash
€135,676
2024 · €63,802+€71,873
Balance sheet total
€470,027
2024 · €510,902-€40,875

Largest movements

2024 to 2025
Assets
  • Current investments -€83,785

    down €83,785 (-22.7%), from €368,662 to €284,877

  • Cash +€71,873

    up €71,873 (+113%), from €63,802 to €135,676

    mainly Current investments (+€83,785) and Depreciation (+€16,334)

  • Tangible fixed assets -€16,334

    down €16,334 (-26.3%), from €62,036 to €45,703

    of which Furniture and vehicles: -€16,334

  • Receivables within one year -€12,629

    down €12,629 (-80.6%), from €15,663 to €3,033

    of which Other amounts receivable: -€13,274

Equity and liabilities
  • Profit (loss) carried forward -€34,378

    down €34,378 (-18.4%), from €186,641 to €152,263

  • Other debts -€7,000

    down €7,000 (-14.0%), from €50,000 to €43,000

Income statement
  • Financial charges +€25,067

    up €25,067 (+32,291%), from €78 to €25,145

    of which Non-recurring financial charges: +€25,080

  • Financial income -€18,650

    down €18,650 (-69.2%), from €26,937 to €8,287

    of which Non-recurring financial income: -€18,344

  • Gross operating margin -€1,955

    down €1,955, from €1,133 to -€822

  • Depreciation -€1,038

    down €1,038 (-6.0%), from €17,372 to €16,334

  • Other operating charges +€114

    up €114 (+45.3%), from €251 to €364

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €10,306
Gross operating margin -€1,955
Staff costs +€63
Depreciation +€1,038
Other operating charges -€114
Financial income -€18,650
Financial charges -€25,067
Result 2025 -€34,378
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€11,912
Investment +€83,785
Financing €0
Cash 2024 €63,802
Net result for the year -€34,378
Depreciation +€16,334
Receivables within one year +€12,629
Trade debts -€483
Tax, wage and social debts +€198
Other debts -€7,000
Accrued charges and deferred income +€787
Current investments +€83,785
Cash 2025 €135,676
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €510,902 €470,027 -€40,875 -8.0%
Fixed assets 21/28 €62,036 €45,703 -€16,334 -26.3%
Tangible fixed assets 22/27 €62,036 €45,703 -€16,334 -26.3%
Land and buildings 22 €14,874 €14,874 = 0.0%
Furniture and vehicles 24 €47,163 €30,829 -€16,334 -34.6%
Current assets 29/58 €448,866 €424,325 -€24,541 -5.5%
Amounts receivable within one year 40/41 €15,663 €3,033 -€12,629 -80.6%
Trade receivables 40 - €644 +€644
Other amounts receivable 41 €15,663 €2,389 -€13,274 -84.7%
Current investments 50/53 €368,662 €284,877 -€83,785 -22.7%
Cash at bank and in hand 54/58 €63,802 €135,676 +€71,873 +113%
Deferred charges and accrued income 490/1 €739 €739 = 0.0%
Total equity and liabilities 10/49 €510,902 €470,027 -€40,875 -8.0%
Equity 10/15 €460,420 €426,042 -€34,378 -7.5%
Contributions 10/11 €247,894 €247,894 = 0.0%
Reserves 13 €25,886 €25,886 = 0.0%
Non-distributable reserves 130/1 €21,991 €21,991 = 0.0%
Reserves not available under the articles 1311 €21,991 €21,991 = 0.0%
Tax-exempt reserves 132 €3,894 €3,894 = 0.0%
Profit (loss) carried forward 14 €186,641 €152,263 -€34,378 -18.4%
Amounts payable 17/49 €50,483 €43,985 -€6,497 -12.9%
Amounts payable within one year 42/48 €50,483 €43,198 -€7,285 -14.4%
Trade debts 44 €483 - -€483
Suppliers 440/4 €483 - -€483
Taxes, remuneration and social security 45 - €198 +€198
Taxes 450/3 - €198 +€198
Other amounts payable 47/48 €50,000 €43,000 -€7,000 -14.0%
Accrued charges and deferred income 492/3 - €787 +€787
Remuneration, social security and pensions 62 €63 - -€63
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €17,372 €16,334 -€1,038 -6.0%
Other operating charges 640/8 €251 €364 +€114 +45.3%
Gross operating margin 9900 €1,133 -€822 -€1,955
Operating profit (loss) 9901 -€16,553 -€17,519 -€967 -5.8%
Financial income 75/76B €26,937 €8,287 -€18,650 -69.2%
Recurring financial income 75 €4,135 €3,829 -€306 -7.4%
Non-recurring financial income 76B €22,802 €4,458 -€18,344 -80.4%
Financial charges 65/66B €78 €25,145 +€25,067 +32,291%
Recurring financial charges 65 €78 €65 -€12 -15.9%
Non-recurring financial charges 66B - €25,080 +€25,080
Profit (loss) for the period before taxes 9903 €10,306 -€34,378 -€44,684
Profit (loss) for the period 9904 €10,306 -€34,378 -€44,684
Profit (loss) for the period to be appropriated 9905 €10,306 -€34,378 -€44,684

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.